老年人中的多药管理干预:对随机对照试验的元分析进行总体综述
Angelica Valz Gris1, Sara Farina1, Martina Porcelli1
1Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Public health
|December 5, 2025
概括
对老年人多种药物管理的干预措施显示出混合的结果. 药物审查可能会减少社区的死亡率,而行为方法可以减少住院治疗,但证据质量较低.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 证据综合 证据综合
背景情况:
- 多药性,即使用多种药物,在老年人中很普遍,并与不良健康结果相关.
- 有效的多药管理策略对于改善健康和减少老龄化人口的医疗负担至关重要.
研究的目的:
- 综合来自随机对照试验 (RCT) 对老年人多药管理干预措施的元分析的证据.
- 评估这些干预措施对关键结果的影响:死亡率,住院和跌倒.
主要方法:
- 系统性审查的总体综述与RCT的元分析.
- 在主要数据库 (PubMed,Cochrane,Web of Science) 进行的搜索截至2024年9月.
- 使用AMSTAR2和GRADE进行质量评估;遵守PRIOR检查清单.
主要成果:
- 包括6篇文章,包括21个元分析 (110个RCT).
- 专注于减缓处方的药物评价在社区环境中降低了死亡率,但不是医院.
- 行为/教育干预措施在减少社区环境中的住院治疗方面最有效.
- 没有任何干预措施显著降低了跌倒风险;整体证据确定性很低.
结论:
- 对老年人多药性干预的证据有限且不一致.
- 以患者为中心,量身定制的策略可能更有益.
- 需要更高质量的标准化试验来为公共卫生战略提供信息.
相关概念视频
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
183
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
212
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
216
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
216
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
221
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
221

